A 1-year randomized controlled trial in 130 Alzheimer's patients found that ALCAR treatment (dosage not specified in abstract) resulted in slower rates of deterioration across 13 of 14 outcome measures, with statistical significance achieved for memory, intelligence, attention, and functional scales
Retrieved from: Institute of Medicine (US) Committee on Military Nutrition Research
An updated meta-analysis of pioglitazone exposure and bladder cancer and comparison to the drug's effect on cardiovascular disease and non-alcoholic steatohepatitis
The red blood cells and platelets are then returned to your body, along with a saline solution to help replace the lost fluid volume
and BAGSVRD, Denmark, Oct
The changes of medium- and long-chain acylcarnitines are not well-studied but their metabolism may have to do with comorbiditic diseases (Table 5)